Medical center

 

(57) Abstract:

The invention relates to medicine and relates to compositions for the prevention of nervous disorders and asthenic States of different etiology and resolve emotional or functional disorders caused by these conditions. The proposed structure of the rhizome contains Kava-Kava (Piper methysticum), the blooming part of melakukannya (Ballota nigra L. ssp.Foetida Hayek), ginseng root (Panax Ginseng), iron gluconate, zinc gluconate, selenium yeast at a certain content of components. The proposed structure more efficient. 1 C.p. f-crystals.

The invention relates to the field of medicine and relates to compositions for the prevention of nervous disorders and asthenic States of different etiology and resolve emotional or functional disorders caused by these conditions.

The pace of modern life, with its daily life, synthetic drugs, additives in food and hygiene products, drugs, alcoholism, General environmental degradation, the rapid development of information technologies, often adverse social situation - all this has an impact on human health, vicotory literature data, 80% of the Russian population lives in a state of chronic stress.

Another problem medicine, in which not less by the above-mentioned reasons, is fatigue (from the Greek astheneia - powerlessness, weakness) (asthenic) syndrome is a painful condition characterized by fatigue, irritable weakness, frequent change of mood, vegetative disorders, sleep disorders.

Fatigue can be associated with metabolic, endocrine, infectious, and mental disorders (reactive neurosis, hypochondria, depression), sleep disorders (chronic insomnia, neurosis, anxiety, shift work) or physical overload (excessive training in sports). Given this context, at present, attempts are being made to develop means of the combined effect. The researchers are increasingly turning to the tools of natural origin, which is the source of elements such as vitamins, hormones, minerals, etc. that play an important role in the normal functioning of all systems of the human body.

For example, it is known restorative and tonic company knoll AG, BASF Pharma, used in asthenic conditions, is a combination of retinamide 0.005 g, ascorbic acid (vitamin C) 0.05 g and caffeine 0,025, the Tool is not effective for nervous and mental disorders.

Known commercial product of the firm Irwin Naturals Super Formula of Antioxidants, vitamin a 20000 IU, vitamin E 200 M, vitamin C 200 mg, selenium 100 mcg, zinc 12 mg calcium, 15 mg, green tea extract, 30 mg and complex, including Ginkgo Biloba, garlic extract, spirulina, grape seed extract, concentrate, carrots, oranges and almonds (Great medical encyclopedia, electronic version). The product is not enough effectivnes to relieve tension and insomnia.

Known drug Trasplant", which is a dry extract from the roots of Kava-Kava in capsule form. The drug is intended for use with neurotic condition, accompanied by anxiety, fear, nervous tension (Mashkovsky, M. D., Medicines, M., 2001, T. 1, S. 87). The drug has limited use.

The objective of the invention is to develop integrated actions aimed at improving the efficiency of prevention of nervous disorders and asthenic States of different etiology and correction obuslovivshei Kava-Kava (Piper methysticum) - 46-56

The blooming part of melakukannya (Ballota nigra L. ssp.Foetida Hayek) content hydroxycitric connections is not less than 2% - 10-16

Ginseng root (Panax Ginseng) - 10-16

Gluconate iron - 4-6

The zinc gluconate - 8-13

Selenium yeast is the content of selenium not less than 1 mcg/mg - 4-6

Moreover, the raw materials previously subjected to cryogenic grinding to an average particle size of 300-400 microns.

Rhizome of Kava-Kava contains as active ingredients dimethoxyaniline, dihydrokavain, dihydromethysticin, kawain, methysticin, flavoring and angonin. The drug reduces the excitability of the Central nervous system, has a calming effect, normalizes sleep, relieves muscle tone, exhibits antiseptic properties. However, the sedative effect of Kava-Kava when used alone is pretty weak. In the proposed structure, it significantly potentiated.

Blocotenol black contains multiple phenylpropanamide glucoside esters, flavonoids, hydroxychalcone derivatives. As raw materials use of air flowering part of the plant with the content hydroxycitric derivatives preferably more than 2%. Introduction in the composition helps to ensure the device is mu preferably the composition is placed in gelatin capsules or tablets with shells.

Ginseng contains triterpene saponosides called ginsenoside, oil, pectin, starch and camphor. In the proposed composition used dried roots of Panax Ginseng Meyer with the content of saponosides not less than 2%, calculated on the D-glyukopiranozil--D-glyukopiranozil-20-S-protopanaxatriol. This component has a stimulating effect on the brain, heart, blood vessels, exerts an antioxidant effect, increases the secretion of histamine, lowers the concentration of glucose in the blood, reduces fatigue, increases physical and mental activity, supports natural libido.

The iron gluconate, di-[D-gluconate]-iron (II), is a greenish-yellow powder with iron content ranging from 11.8 to 12.5 percent. He shows immuno-stimulating effect and is essential for erythropoiesis. It is known that iron is an essential component of hemoglobin and myoglobin, as well as a cofactor of some key enzymes. The introduction of iron gluconate in the composition provides more energy for the hard work, reduces irritability and lethargy.

Zinc is an element of the more than 80 known enzymes and may be useful for various n promotes division, the growth and regeneration of cells. This component is involved in the reactions anticyclone. In combination with iron gluconate provides stability increase attention and improve short-term memory.

Selectabase yeast are dry Baker's yeast, selenium-enriched. Produced by culturing the yeast in a nutrient medium in the presence of selectabase substances. Selenium as well as zinc, iron, refers to the essential trace elements, i.e. in the absence or deficiency which the body can't grow and develop. In addition, he shows effective anti-oxidant, stimulates the immune system. There is the potential ability of selenium to prevent the development of degenerative disorders in humans. Generally, in various complex vitamin-mineral preparations use inorganic forms of selenium, such as sodium Selenite. Selectabase yeast in contrast to such selenium compounds do not exhibit toxicity.

An example embodiment of the invention.

To prepare take 50% raw Kava-Kava, 13% of the raw materials of melakukannya, 15% raw ginseng, 5% iron gluconate, 12% zinc gluconate, 5% village freezing at a temperature of -50oS. ..-80oWhen contact with liquid nitrogen and then pulverized at a low temperature and in contact with liquid nitrogen, sieved through a sieve with a mesh size of 400 μm. Powders contribute consistently to the mixer type Nautamix and stirred at high speed for 20 minutes. Then the resulting mixture is optionally Packed in capsules. This form is simple and easy to use, allows you to mask the taste, ensures complete safety properties and excludes operations that can cause changes, such as compression.

The effectiveness of the drug was tested on human volunteers and has shown high efficacy in asthenia, nervousness, cerebral insufficiency, physical and mental strain, dystonia, depression. The proposed system can be widely used in medical practice.

1. Medical center for the prevention of nervous disorders and asthenic States of different etiology and resolve emotional or functional disorders caused by these conditions, characterized in that it contains shredded cryogenic way up to average particle sizes of 300-400 microns rhizome to the changes at least 2%, ginseng root (Rapach Ginseng), iron gluconate, zinc gluconate, selenium yeast for the following component content, %:

Rhizome Kava-Kava (Piper methysticum) - 46 - 56

Flowering part of melakukannya (Ballota nigra L. ssp. Foetida Hayek) content hydroxycitric connections is not less than 2% - 10 - 16

Ginseng root (Rapach Ginseng) - 10 - 16

Gluconate iron - 4 - 6

The zinc gluconate - 8 - 13

Selenium yeast is the content of selenium not less than 1 mcg/mg - 4-6

2. Complex p. 1, characterized in that it is placed in the capsule.

 

Same patents:

The invention relates to medicine

The invention relates to medicine, specifically to means of therapy dementia

The invention relates to new pyrazole[3,4-d]pyrimidines having anticonvulsant and anti-allergic/asthma action methods for their preparation (options) and pharmaceutical compositions based on them
The invention relates to medicine, namely to dentistry, and for sedation in dental surgeries

New salt // 2193560
The invention relates to a new salt - acid tartrate (R)-3-N,N-dicycloverine-8-fluoro-3,4-dihydro-2H-1-benzopyran-5-carboxamide, in particular its (2R, 3R)-tartrate and especially acid monohydrate (2R,3R)-tartrate of (R)-3-N,N-dicycloverine-8-fluoro-3,4-dihydro-2H-1-benzopyran-5-carboxamide, as well as to a method for the specified tartrate salts and pharmaceutical compositions based on it for the treatment and prevention of disorders of the Central nervous system and related medical abuses associated with the activity of the antagonist 5-HT1A-receptor

The invention relates to pharmacology and medicine, in particular to a method of treatment of Alzheimer's disease and pharmaceutical compositions on the basis of climinal for treatment

The invention relates to novel condensed pyrrolo (2,3-C)carbazole-6-Onam represented by the General formulas (I) and (II)

The invention relates to medicine, namely to anesthesiology and critical care medicine

The invention relates to the field of medicine and medical equipment, and concerns the application sulfamido General formula (I) as therapeutically active substances for disorders of the Central nervous system and for the preparation of the drugs
The invention relates to medicine

Medical center // 2194522
The invention relates to the field of medicine and related compounds with immune stimulating and regulating metabolic processes in the body by the action of

The invention relates to pharmaceutical compositions for oral administration amide N-piperidine-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methylpyrazole-3-carboxylic acid of the formula

< / BR>
its pharmaceutically acceptable salt and solvate, referred to as compounds of formula 1

The invention relates to medicine, in particular to the method of manufacture used oral solid dosage forms with controlled release of active substances, with at least three of the four contains the active substance or combination of active ingredients of the compositions of the tablets (comprimate) can vary in their content and the number and processed into solid dosage forms using minimal equipment and minimal expenditure of time

The invention relates to medicine, in particular to pharmaceutical drug used for functional disorders of the urinary symptoms associated with benign prostatic hyperplasia

The invention relates to medicine and relates to a method of producing an antibacterial agent, comprising mixing the active ingredients in doxycycline hydrochloride with calcium stearate, lactose, potato starch and filling the mixture gelatin capsules with the mixture of ingredients is preloaded into the mixture with stirring for 3-5 minutes add 5-10% calcium stearate from the calculated amount, the mixture is dried to a residual moisture content of 2.5 to 4.5%, add the remaining amount of calcium stearate obtained dry mixture contribute in gelatin capsules, pre-treated with an inert gas at a feed rate of the gas 3-5 m/s
The invention relates to medicine, in particular to novel solid pharmaceutical compositions containing hexadecylphosphocholine (miltefosine) for oral administration in the treatment of leishmaniasis, to a method for the production of specified pharmaceutical compositions for the treatment of leishmaniasis specified pharmaceutical composition to a combination that includes the specified solid pharmaceutical composition, an antiemetic and/or antidiarrheal agent

The invention relates to medicine, namely to a method for gastrointestinal drug in gelatin capsules
The invention relates to the field of pharmacology, and relates to antibacterial drugs

The invention relates to the preparation, for example, in the form of capsules, soft coated, containing as active ingredient cyclosporine

Medical center // 2194522
The invention relates to the field of medicine and related compounds with immune stimulating and regulating metabolic processes in the body by the action of
Up!